Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:39:39 UTC |
---|
Update Date | 2021-09-26 23:17:32 UTC |
---|
HMDB ID | HMDB0259772 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide |
---|
Description | N-(4-hydroxy-2-methylphenyl)icosa-5,8,11,14-tetraenamide belongs to the class of organic compounds known as anilides. These are organic heterocyclic compounds derived from oxoacids RkE(=O)l(OH)m (l not 0) by replacing an OH group by the NHPh group or derivative formed by ring substitution. Based on a literature review very few articles have been published on N-(4-hydroxy-2-methylphenyl)icosa-5,8,11,14-tetraenamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (5z,8z,11z,14z)-n-(4-hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=C(C)C=C(O)C=C1 InChI=1S/C27H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-27(30)28-26-22-21-25(29)23-24(26)2/h7-8,10-11,13-14,16-17,21-23,29H,3-6,9,12,15,18-20H2,1-2H3,(H,28,30) |
---|
Synonyms | Value | Source |
---|
N-(2-Methyl-3-hydroxyphenyl)-5,8,11,14-eicosatetraenamide | MeSH |
|
---|
Chemical Formula | C27H39NO2 |
---|
Average Molecular Weight | 409.614 |
---|
Monoisotopic Molecular Weight | 409.2980795 |
---|
IUPAC Name | N-(4-hydroxy-2-methylphenyl)icosa-5,8,11,14-tetraenamide |
---|
Traditional Name | N-(4-hydroxy-2-methylphenyl)icosa-5,8,11,14-tetraenamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=C(C)C=C(O)C=C1 |
---|
InChI Identifier | InChI=1S/C27H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-27(30)28-26-22-21-25(29)23-24(26)2/h7-8,10-11,13-14,16-17,21-23,29H,3-6,9,12,15,18-20H2,1-2H3,(H,28,30) |
---|
InChI Key | WUZWFRWVRHLXHZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as anilides. These are organic heterocyclic compounds derived from oxoacids RkE(=O)l(OH)m (l not 0) by replacing an OH group by the NHPh group or derivative formed by ring substitution. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Anilides |
---|
Direct Parent | Anilides |
---|
Alternative Parents | |
---|
Substituents | - Anilide
- M-cresol
- N-arylamide
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Toluene
- Fatty amide
- Fatty acyl
- Secondary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Organic oxide
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
(5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=C(C)C=C(O)C=C1 | 4458.8 | Standard polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=C(C)C=C(O)C=C1 | 3215.9 | Standard non polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=C(C)C=C(O)C=C1 | 3524.9 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C)C=C1C)[Si](C)(C)C | 3298.8 | Semi standard non polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C)C=C1C)[Si](C)(C)C | 3125.2 | Standard non polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C)C=C1C)[Si](C)(C)C | 3281.1 | Standard polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TBDMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1C)[Si](C)(C)C(C)(C)C | 3765.3 | Semi standard non polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TBDMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1C)[Si](C)(C)C(C)(C)C | 3380.4 | Standard non polar | 33892256 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide,2TBDMS,isomer #1 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1C)[Si](C)(C)C(C)(C)C | 3351.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fk9-5983000000-d545fea93c80b9906992 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
---|